Department of Pharmaceutics, Faculty of Pharmacy, Beni Sueif University, Beni Sueif, Egypt.
AAPS PharmSciTech. 2009;10(4):1336-42. doi: 10.1208/s12249-009-9335-x. Epub 2009 Nov 10.
Ofloxacin, available as ophthalmic solution, has two major problems: first, it needs frequent administration every 4 hours or even every 1 hour to treat severe eye infection; second, there is formation of white crystalline deposit on cornea due to its pH-dependent solubility, which is very low at pH of corneal fluid. In order to provide a solution to previous problems, ofloxacin in this study is prepared as topically effective in situ thermosensitive prolonged release liposomal hydrogel. Two preparation procedures were carried out, leading to the formation of multilamellar vesicles (MLVs) and reverse-phase evaporation vesicles (REVs) at pH 7.4. Effects of method of preparation, lipid content, and charge inducers on encapsulation efficiency were studied. For the preparation of in situ thermosensitive hydrogel, chitosan/beta-glycerophosphate system was synthesized and used as carrier for ofloxacin liposomes. The effect of addition of liposomes on gelation temperature, gelation time, and rheological behaviors of the hydrogel were evaluated. In vitro transcorneal permeation was also determined. MLVs entrapped greater amount of ofloxacin than REVs liposomes at pH 7.4; drug loading was increased by including charge-inducing agent and by increasing cholesterol content until a certain limit. The gelation time was decreased by the addition of liposomes into the hydrogel. The prepared liposomal hydrogel enhances the transcorneal permeation sevenfold more than the aqueous solution. These results suggested that the in situ thermosensitive ofloxacin liposomal hydrogel ensures steady and prolonged transcorneal permeation, which improves the ocular bioavailability, minimizes the need for frequent administration, and decreases the ocular side effect of ofloxacin.
第一,治疗严重眼部感染时,需要每 4 小时甚至每 1 小时滴注一次,使用频率较高;第二,由于其 pH 依赖性溶解度较低,在角膜液的 pH 值下,会在角膜上形成白色结晶沉积物。为了解决以前的问题,本研究将氧氟沙星制备成局部有效的原位热敏延长释放脂质体水凝胶。进行了两种制备程序,导致在 pH 7.4 下形成多层囊泡(MLVs)和反相蒸发囊泡(REVs)。研究了制备方法、脂质含量和电荷诱导剂对包封效率的影响。为了制备原位热敏水凝胶,合成了壳聚糖/β-甘油磷酸体系,并用作氧氟沙星脂质体的载体。评估了加入脂质体对凝胶温度、凝胶时间和水凝胶流变行为的影响。还测定了体外透角膜渗透。在 pH 7.4 下,MLVs 包封的氧氟沙星多于 REVs 脂质体;通过加入电荷诱导剂和增加胆固醇含量,直到达到一定的限制,药物载量增加。加入脂质体可降低水凝胶的凝胶时间。所制备的脂质体水凝胶使透角膜渗透增加了七倍,超过了水溶液。这些结果表明,原位热敏氧氟沙星脂质体水凝胶可确保稳定且延长的透角膜渗透,从而提高眼部生物利用度,减少频繁给药的需要,并减少氧氟沙星的眼部副作用。